Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fluorometric determination of hydroflumethiazide in human plasma and urine after its oral administration

  • 22 Accesses

  • 8 Citations


A spectrofluorometric method for determination of hydroflumethiazide in human plasma and urine has been developed. The limit of detection was 10 ng/ml plasma and 100 ng/ml urine. The plasma concentration of hydroflumethiazide was determined for 9–11 hours and excretion in urine for 24–37 hrs after oral administration of about 1 mg/kg body weight to 7 subjects. Plasma half life in healthy subjects was 1.9–2.1 h, and 2.7–8.6 h in patients during the period 4–9 hrs after dosing. Cumulative excretion in urine was 67–79% of the dose during 31–37 hrs in 6 subjects; one patient with renal disease was found to excrete only 25.8% of dose during 24 hours. Renal clearance of hydroflumethiazide was higher in the healthy subjects (0.29–0.44 1 h−1 kg−1) than in the patients (0.040–0.15 l h−1 kg−1). Plasma half life of hydroflumethiazide was not closely correlated with renal clearance of the drug, which suggests that other factors may play a role in determining plasma half life.

This is a preview of subscription content, log in to check access.


  1. 1.

    Blagg, C. R.: Hydroflumethiazide — a new oral diuretic. Lancet1959 II, 311–313

  2. 2.

    Dettli, L., Spring, P.: Vergleichende pharmakologische Prüfung eines neuen Salidiureticums (Cyclopenthiazid) am gesunden Menschen. Z. ges. exp. Med. exp. Chir.134, 310–322 (1960)

  3. 3.

    Young, D. S., Forrester, T. M., Morgan, T. N.: A comparison of the diuretic action of the chlorothiazide analogues. Lancet1959 II, 765–768

  4. 4.

    Matheson, N. A., Morgan, T. N.: Diuretic action of chlorothiazide. Lancet1958 I, 1195–1199

  5. 5.

    Ford, R. V., Moyer, J. H., Spurr, C. L.: Clinical and laboratory observations on chlorothiazide (Diuril). Arch. int. Med.100, 582–592 (1957)

  6. 6.

    Tapia, F. A.: Diuretic and antihypertensive effects of polythiazide. Curr. ther. Res.3, 365–377 (1961)

  7. 7.

    Ford, R. V.: Clinical pharmacological investigation of polythiazide, a potent oral diuretic agent. Curr. ther. Res.3, 320–329 (1961)

  8. 8.

    Hutcheon, D. E., Leonard, G. B.: Therapeutic efficacy of diuretics with different durations of action. J. Amer. med. Ass.185, 640–642 (1963)

  9. 9.

    Beevers, D. G., Harpur, J. E., Hamilton, M.: The long-term treatment of hypertension with thiazide diuretics. Postgrad. med. J.47, 639–643 (1971)

  10. 10.

    Maronde, R. F., Milgrom, M., Dickey, J. M.: Potassium loss with thiazide therapy. Amer. Heart. J.78, 16–21 (1969)

  11. 11.

    Skovbo, P., Bjerregaard, P., Hvidt, R., Jesting, E., Lorentzen, F., Hvidt, S.: Diuretika og hypokaliæmi. Ugeskr. Læg.134, 1043–1047 (1972)

  12. 12.

    Reutter, F., Schaub, F.: Harnsäurestoffwechsel und Salidiuretica. Dtsch. med. Wschr.89, 1101–1104 (1964)

  13. 13.

    Heimsoth, V., Harmann, F.: Untersuchungen zur Störung des Harnsäurestoffwechsels nach Saluretica-Verabreichung. Dtsch. med. Wschr.90, 1905–1908 (1965)

  14. 14.

    Roediger, P. M., Alden, J., Beardwood, D., Hutchison, J. C.: Benzothiadiazines and diabetes mellitus. II. Comparison of hyperglycemic effects of bendroflumethiazide and chlorothiazide in hypertensive patients with diabetes mellitus. Curr. ther. Res.6, 670–677 (1964)

  15. 15.

    Runyan, J. W.: Influence of thiazide diuretics on carbohydrate metabolism in patients with mild diabetes. New Engl. J. Med.267, 541–543 (1962)

  16. 16.

    Garceau, Y., Davis, J., Hasegawa, J.: Quantitative TLC procedure for determination of hydroflumethiazide in biological fluids. J. pharm. Sci.63, 1793–1795 (1974)

  17. 17.

    Vandenheuvel, W. J. A., Gruber, V. F., Walker, R. W., Wolf, F. J.: GLC analysis of hydrochlorothiazide in blood and plasma. J. pharm. Sci.64, 1309–1312 (1975)

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Brørs, O., Jacobsen, S. & Arnesen, E. Fluorometric determination of hydroflumethiazide in human plasma and urine after its oral administration. Eur J Clin Pharmacol 11, 149–154 (1977).

Download citation

Key words

  • Hydroflumethiazide
  • spectrofluorometry
  • pharmacokinetics
  • plasma half life
  • renal excretion
  • renal disease